Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

OXTR agonists may promote hair growth and be effective for treating hair loss.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Trilostane effectively treated hair loss in Alaskan Malamutes with no adverse effects.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Compound 4 is a promising treatment for hair loss with low toxicity.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Recent advancements in hair loss treatments include new therapies and insights for different types of alopecia.

Energy healing treatment improved flutamide's solubility and stability, potentially enhancing its effectiveness for prostate cancer.

Short-term finasteride use in male rats caused anxiety, depression, and memory problems.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.

Semaglutide may worsen eating disorders in vulnerable individuals.

Ritlecitinib effectively regrows hair in severe alopecia areata, especially in adolescents.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

New, safer treatments for children's hair disorders are needed, and better evaluation methods are recommended.

The document concludes that compulsive hair disorders, like trichotillomania, are complex and require careful diagnosis and treatment from both psychiatric and dermatological perspectives.

Tianmeng oral liquid may help with insomnia, anxiety, and depression.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

SSRIs may help manage sexual behavior in dementia patients, but they can cause long-lasting sexual dysfunction.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Finasteride and intense pulsed light effectively reduce unwanted facial hair in women, but may not be cost-effective.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.